How is the Yale‑Brown Obsessive‑Compulsive Scale – Second Edition (Y‑BOCS‑II) scored and interpreted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Y-BOCS-II Scoring and Interpretation

The Y-BOCS-II is scored from 0-40 points (10 items, each rated 0-4), with severity classifications of 0-7 (subclinical), 8-15 (mild), 16-23 (moderate), and 24-31 (severe), where a clinically meaningful treatment response requires ≥35% reduction from baseline. 1, 2

Scoring Structure

  • The scale consists of 10 items, each rated from 0 (no symptoms) to 4 (extreme symptoms), yielding a total score range of 0-40 points 3, 4
  • Obsessions and compulsions each contribute separate subscale scores of 0-20 points 5, 4
  • The Y-BOCS-II quantifies severity based on three core parameters: time spent on obsessions/compulsions, distress levels, and degree of functional interference in daily activities 1, 2

Severity Classification Ranges

  • 0-7 points: Subclinical symptoms 1, 2
  • 8-15 points: Mild OCD 1, 2
  • 16-23 points: Moderate OCD 1, 2
  • 24-31 points: Severe OCD 1, 2
  • ≥28 points: Threshold for severe, treatment-refractory OCD requiring consideration of neurosurgical interventions (or ≥14 if only obsessions or only compulsions are present) 1

Diagnostic Utility

  • A cut-off score of 13 on the Y-BOCS-II total score demonstrates optimal discriminatory ability for OCD diagnosis, with sensitivity of 85-90% and specificity of 94-97% 6
  • The scale shows excellent accuracy in discriminating between OCD patients and controls (AUC = 0.96) as well as patients with other mood and anxiety disorders (AUC = 0.93) 6

Treatment Monitoring Applications

  • A reduction of ≥35% from baseline Y-BOCS-II scores defines clinically meaningful treatment response 1, 2
  • The scale effectively tracks symptom reduction across treatment, for example from severe range (score of 24) to subclinical (score of 3) following exposure and response prevention therapy 1
  • The Y-BOCS-II demonstrates enhanced ability to detect fluctuations in symptom severity among extremely ill patients compared to the original Y-BOCS 7

Key Improvements Over Original Y-BOCS

  • The Y-BOCS-II systematically incorporates avoidance behaviors into the scoring framework, addressing a major limitation of the original scale 7, 4
  • Modified item content and scoring framework provide more comprehensive evaluation of symptom severity, especially in extremely ill patients 7, 4
  • The scale maintains strong convergence with the original Y-BOCS while offering improved sensitivity 7

Psychometric Properties

  • The Y-BOCS-II demonstrates excellent internal consistency (Cronbach's α = 0.86-0.96) 4, 8, 6
  • Test-retest reliability is high (r = 0.64-0.94) 4, 8, 6
  • Interrater reliability is excellent (ICC > 0.85-0.99) 4, 8
  • Factor analysis reveals a two-factor structure consistent with Obsession and Compulsion Severity subscales 4, 8, 6

Administration Requirements

  • The Y-BOCS-II must be administered by clinicians trained in recognizing nuanced OCD presentations to ensure accurate scoring 1, 2
  • The scale should be administered alongside thorough clinical assessment of specific obsession/compulsion content, as the Y-BOCS-II itself is content-independent 1, 2
  • Clinicians can obtain both Y-BOCS and Y-BOCS-II scores within one administration by adding Y-BOCS item 4 to the Y-BOCS-II assessment, then "back-coding" the ratings 7

Critical Clinical Pitfalls to Avoid

  • Avoidance behaviors lead to systematic underestimation of symptom severity on the Y-BOCS-II, as patients who extensively avoid triggering situations spend less time on active obsessions/compulsions, artificially lowering scores despite severe functional impairment 1, 2
  • Family accommodation assessment must accompany Y-BOCS-II administration, as relationship partners or family members who provide reassurance or participate in rituals affect the accuracy of interference ratings 1, 2
  • The content-independent nature of the scale requires clinical expertise to properly categorize symptoms and distinguish OCD from other conditions with intrusive thoughts 9, 2

References

1
Guideline

Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Scoring Interpretation and Clinical Application

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2
Guideline

Assessing OCD Symptom Severity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

CY-BOCS Score Interpretation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

9
Guideline

obsessive-compulsive disorder.

Nature Reviews Disease Primers, 2019

Related Questions

How should I document Yale‑Brown Obsessive‑Compulsive Scale – Second Edition (Y‑BOCS‑II) scoring for a 32‑year‑old female with obsessive‑compulsive disorder, including item scores, subscale totals, severity interpretation, clinical impression, and treatment plan?
When assessing a patient with obsessive‑compulsive disorder, should I use the Yale‑Brown Obsessive‑Compulsive Scale (Y‑BOCS) or the revised Yale‑Brown Obsessive‑Compulsive Scale – Second Edition (Y‑BOCS‑II)?
How do I interpret the Yale‑Brown Obsessive‑Compulsive Scale (Y‑BOCS) total score?
What is the treatment for a patient with a Y-BOCS (Yale-Brown Obsessive Compulsive Scale) score of 28 indicating severe obsessive-compulsive disorder symptoms?
Can the Yale‑Brown Obsessive‑Compulsive Scale (Y‑BCOS) be used to diagnose obsessive‑compulsive disorder?
What is the expected recovery time after a hysterectomy (abdominal, laparoscopic/robot‑assisted, or vaginal) for an adult woman, and how do factors such as age, obesity, diabetes, or cardiovascular disease affect it?
In a 4‑year‑old child with presumed bacterial conjunctivitis, what is the recommended topical ofloxacin dosing regimen and safety considerations?
How should I evaluate and manage a patient with normal laboratory studies who has palpitations, a resting heart rate of 90‑110 bpm (tachycardia), intermittent dizziness, loss of balance while walking, and occasional nausea?
What laboratory tests should be ordered for a patient with pitting edema of the lower extremities, fatty enlarged liver, and known cirrhosis?
After confirmed exposure to Mycobacterium tuberculosis, what immediate medical evaluation, screening, and treatment steps are recommended?
What is the recommended evaluation and treatment for orchitis in adolescents and sexually active men?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.